NEW YORK, Nov. 26, 2015 /PRNewswire/ -- Future Market
Insights offers a 10-year forecast of the global respiratory
inhaler devices market between 2015 and 2025. In terms of value,
the market is expected to register a CAGR of 4.3% during the
projected period. This study demonstrates market dynamics and
trends in all seven regions that influence the current environment
and future status of the respiratory inhaler devices market over
the forecast period.
Report Description
This Future Market Insights report examines the respiratory inhaler
devices market for the period 2015–2025. The primary objective of
the report is to offer insights into developments in the
respiratory inhaler devices market that are significantly
transforming global businesses and enterprises. Increasing
prevalence of asthma, COPD and other respiratory diseases coupled
with rising awareness is predicted to increase usages of
respiratory inhaler devices worldwide. This is expected to bolster
growth of the respiratory inhaler devices market over the next five
to six years. Increasing demand for inhalation respiratory inhaler
devices for controlling asthma and other respiratory disease,
especially among children and elderly population, is expected to
drive growth of respiratory inhaler devices market during the
forecast period. Companies are focusing on regions and sections
where prevalence of asthma, and chronic lung disease are increasing
such as Asia Pacific and MEA.
The respiratory inhaler devices market report begins with an
overview of the respiratory inhaler devices market in terms of
value. This section includes FMI analysis of key trends, drivers
and restraints and opportunity, which are factors influencing
growth of the respiratory inhaler devices market. Impact analysis
of key growth drivers and restraints based on the weighted average
model is included in the respiratory inhaler devices market report
to better equip clients with crystal clear decision-making
insights.
The global respiratory inhaler devices market is segmented on the
basis of products type into dry powder inhaler (DPI), metered dose
inhaler (MDI) and nebuliser. Nebuliser is further sub-segmented
into compressed air nebuliser, ultrasonic nebuliser and mesh
nebuliser. A detailed analysis has been provided for every segment
and sub-segment in terms of market size, Y-o-Y growth rate,
absolute $ opportunity and BPS analysis.
The next section of the report highlights respiratory inhaler
devices adoption by region. It provides a market outlook for
2015–2025 and sets the forecast within the context of the
respiratory inhaler devices market. The study discusses key
regional trends contributing to growth of the respiratory inhaler
devices market worldwide, as well as analyses the extent to which
drivers are influencing this market in each region. Key regions
assessed in this report include North
America, Latin America,
Western Europe, Eastern Europe, Asia Pacific Excluding Japan
(APEJ), Japan and Middle East & Africa.
The above sections – by product type and region – evaluate the
present scenario and growth prospects of the respiratory inhaler
devices market for the period 2015 –2025. We have considered 2014
as the base year and provide data for the forecast period.
To ascertain respiratory inhaler devices market size, we have also
considered revenue generated by manufacturers. The forecast
presented here assesses the total revenue by value across the
respiratory inhaler devices market. In order to offer an accurate
forecast, we started by sizing the current market, which forms the
basis of how the respiratory inhaler devices market is expected to
develop in the future. Given the characteristics of the market, we
triangulated the outcome of three different types of analysis,
based on supply side, downstream industry demand and the economic
envelope.
In addition, it is imperative to note that in an ever-fluctuating
global economy, we not only conduct forecasts in terms of CAGR, but
also analyse on the basis of key parameters such as year-on-year
(Y-o-Y) growth rates to understand the predictability of the market
and to identify the right opportunities across the respiratory
inhaler devices market.
The respiratory inhaler devices segments in terms of product and
regions are analysed in terms of Basis Point Share (BPS) to
understand individual segment's relative contributions to market
growth. This detailed level of information is important for
identification of various key trends in the respiratory inhaler
devices market.
Another key feature of this report is the analysis of key segments
in terms of absolute dollar opportunity. This is traditionally
overlooked while forecasting the market. However, absolute dollar
opportunity is critical for assessing the level of opportunity that
a provider can look to achieve, as well as to identify potential
resources from a sales and delivery perspective of the respiratory
inhaler devices market.
To understand key growth segments in terms of growth and adoption
for dry powder inhaler, metered dose inhaler and nebuliser across
the globe in the near future, Future Market Insights developed the
respiratory inhaler devices market 'Attractiveness Index'. The
resulting index should help providers identify real market
opportunities.
In the final section of the report, respiratory inhaler devices
'Competitive Landscape' is included to provide report audiences
with a dashboard view, based on categories of providers in the
value chain of the respiratory inhaler devices product portfolio
and key differentiators. Key categories of providers covered in the
report are respiratory inhaler devices manufacturers. This section
is primarily designed to provide clients with an objective and
detailed comparative assessment of key providers specific to a
market segment in the respiratory inhaler devices value chain and
the potential players for the same. Report audiences can gain
segment-specific vendor insights to identify and evaluate key
competitors based on in-depth assessment of capabilities and
successes in respiratory inhaler devices marketplace.
Detailed profiles of the providers are also included in the scope
of the report to evaluate their long-term and short-term
strategies, key offerings and recent developments in the
respiratory inhaler devices market. Key competitors covered in
terms of manufacturers include AstraZeneca, Beximco Pharmaceuticals
Ltd., Boehringer Ingelheim GmbH, Cipla Ltd., GlaxoSmithKline plc,
Koninklijke Philips N.V., Merck & Co., Inc., OMRON Healthcare
Europe B.V., PARI Medical Holding and Teva Pharmaceutical
Industries Ltd.
Key Segments Covered
Product Type
Dry Powder Inhaler
Metered Dose Inhaler
Nebulizer
Ultrasonic Nebulizer
Compressed Air Nebulizer
Mesh Nebulizer
By Disease Indication
Asthma
COPD
Pulmonary Arterial Hypertension
Others Respiratory Disease
By Technology
Manually Operated Inhaler Devices
Digitally Operated Inhaler Devices
Key Regions/Countries Covered
North America
U.S.
Canada
Latin America
Brazil
Argentina
Mexico
Western Europe
EU5
Nordics
BENELUX
Rest of Western Europe
Eastern Europe
Poland
Russia
Rest of Eastern Europe
Asia Pacific Excluding Japan (APEJ)
Greater China
India
ASEAN
Australia and New Zealand
Rest of APEJ
Japan
Middle East & Africa
GCC
South Africa
Israel
Turkey
Rest of MEA
Key Companies
AstraZeneca
Beximco Pharmaceuticals Ltd.
Boehringer Ingelheim GmbH
Cipla Ltd.
GlaxoSmithKline plc
Koninklijke Philips N.V.
Merck & Co., Inc.
OMRON Healthcare Europe B.V.
PARI Medical Holding
Teva Pharmaceutical Industries Ltd.
Read the full report:
http://www.reportlinker.com/p03405787-summary/view-report.html
About Reportlinker
ReportLinker is an award-winning market research solution.
Reportlinker finds and organizes the latest industry data so you
get all the market research you need - instantly, in one place.
http://www.reportlinker.com
__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/respiratory-inhaler-devices-market-global-industry-analysis-and-opportunity-assessment-2015--2025-300184871.html
SOURCE Reportlinker